Supplementation of amino acids to prevent reperfusion injury after liver surgery and transplantation - Where do we stand today?

Clinical Nutrition

Volumn 30, Issue 2, 2011, Pages 143-147

  Hoffmann, Katrin ^a   Büchler, Markus W ^a   Schemmer, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Amino acids; Ischemia reperfusion injury; Kupffer cells; Liver surgery

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; AMINO ACID; ARGININE; AUTACOID; CHLORIDE CHANNEL; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLYCINE; INTERLEUKIN 10; INTERLEUKIN 4; LACTATE DEHYDROGENASE; MALONALDEHYDE; METHIONINE; PHOSPHOLIPASE A2; PLACEBO; PREDNISOLONE; TAURINE;

AMINO ACID SUPPLEMENTATION; CELL INFILTRATION; CELL INTERACTION; CHANNEL GATING; CLINICAL TRIAL (TOPIC); CYTOKINE RELEASE; DIET SUPPLEMENTATION; ENDOTHELIUM CELL; ENZYME INHIBITION; GRAFT SURVIVAL; HUMAN; INHIBITION KINETICS; KUPFFER CELL; LEUKOCYTE; LIPID PEROXIDATION; LIVER BLOOD FLOW; LIVER MICROCIRCULATION; LIVER PROTECTION; LIVER SINUSOID; LIVER SURGERY; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MICROCIRCULATION; NONHUMAN; POLYMORPHONUCLEAR CELL; REPERFUSION INJURY; REVIEW; SWINE; SYSTEMATIC REVIEW;

ACETYLCYSTEINE; AMINO ACIDS; GLYCINE; HEPATECTOMY; HUMANS; KUPFFER CELLS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MICROCIRCULATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPERFUSION INJURY;

EID: 79953038985     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2010.09.006     Document Type: Review

References (71)

1. Belghiti J., Hiramatsu K., Benoist S. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000, 191:38-46.
2. Jarnagin W.R., Gonen M., Fong Y. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 2002, 236:397-406.
3. Schemmer P., Bruns H., Weitz J., Schmidt J., Büchler M.W. Liver transection using vascular stapler. HPB 2008, 10:249-252.
4. Schemmer P., Friess H., Hinz U., Mehrabi A., Kraus T.W., Z'graggen K., et al. Stapler hepatectomy is a safe dissection technique: analysis of 300 patients. World J Surg 2006, 30(3):419-430.
5. Poon R.T., Fan S.T., Lo C.M., Liu C.L., Lam C.M., Yuen W.K., et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases - analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004, 240:698-710.
6. Moussa M.E., Sarraf C.E., Uemoto S. Effect of total hepatic vascular exclusion during liver resection on hepatic ultrastructure. Liver Transpl Surg 1996, 2:461-467.
7. Howard T.K., Klintmalm G.B., Cofer J.B., Husberg B.S., Goldstein R.M., Gonwa T.A. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990, 49:103-107.
8. Schemmer P., Connor H.D., Arteel G.E., Raleigh J.A., Bunzendahl H., Mason R.P., et al. Reperfusion injury in livers due to gentle in situ organ manipulation during harvest involves hypoxia and free radicals. J Pharmacol Exp Ther 1999, 290:235-240.
9. Klar E., Kraus T., Osswald B.R. Necessity of a recovery phase after in situ preparation to improve hepatic microcirculation prior to organ preservation. Transplant Proc 1996, 28:1867-1868.
10. Schemmer P., Schoonhoven R., Swenberg J.A., Bunzendahl H., Thurman R.G. Gentle in situ liver manipulation during organ harvest decreases survival after rat liver transplantation: role of Kupffer cells. Transplantation 1998, 65(8):1015-1020.
11. Serracino-Inglott F., Habib N.A., Mathie R.T. Hepatic ischemia-reperfusion injury. Am J Surg 2001, 181:160-166.
12. Thurman R.G., Bunzendahl H., Lemasters J.J. Role of sinusoidal lining cells in hepatic reperfusion injury following cold storage and transplantation. Semin Liver Dis 1993, 13(1):93-100.
13. Vollmar B., Glasz J., Leiderer R. Hepatic microcirculatory perfusion failure is a determinant for liver dysfunction in warm ischemia-reperfusion. Am J Pathol 1994, 145:1421-1423.
14. Kawada N., Tran-Thi T.A., Klein H., Decker K. The contraction of hepatic stellate cells stimulated with vasoactive substances - possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 1993, 213:815-823.
15. Walsh K.B., Toledo A.H., Rivera-Chavez F.A., Lopez-Neblina F., Toledo-Pereyra L.H. Inflammatory mediators of liver ischemia-reperfusion injury. Exp Clin Transplant 2009, 7(2):78-93.
16. Schemmer P., Bradford B.U., Bunzendahl H., Lemasters J.J., Thurman R.G. Gentle in situ liver manipulation during organ harvest increases oxygen consumption in the liver. Transplant Proc 2000, 32(1):112.
17. Bremer C., Bradford B.U., Hunt K.J., Knecht K.T., Connor H.D., Mason R.P., et al. Role of Kupffer cells in the pathogenesis of hepatic reperfusion injury. Am J Phys 1994, 267:G630-G636.
18. Schemmer P., Mehrabi A., Kraus T., Sauer P., Gutt C.N., Uhl W., et al. New aspects on reperfusion injury to liver - impact of organ harvest. Nephrol Dial Transplant 2004, 19(Suppl. 4):26-35.
19. Lemasters J.J., Thurmann R.G. Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol 1997, 37:327-338.
20. Nukina S., Fusaoka T., Thurman R.G. Glycogenolytic effect of adenosine involves ATP from hepatocytes and eicosanoids from Kupffer cells. Am J Phys 1994, 266(1):G99-G105.
21. Bouwens L. Structural and functional aspects of Kupffer cells. Revis Biol Celular 1988, 16:69-94.
22. Fusaoka T., Hunt K.J., Lemasters J.J., Thurmann R.G. Evidence that activation of Kupffer cells increases oxygen uptake after cold. Transplantation 1994, 58:1067-1071.
23. Schemmer P., Enomoto N., Bradford B.U., Bunzendahl H., Raleigh J.A., Lemasters J.J., et al. Activated Kupffer cells cause a hypermetabolic state after gentle in situ manipulation of liver in rats. Am J Phys 2001, 280:G1076-G1082.
24. Zhong Z., Wheeler M.D., Li X., Froh M., Schemmer P., Yin M., et al. L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Care 2003, 6:229-240.
25. Schemmer P., Bunzendahl H., Herfarth C., Klar E., Thurman R.G. Arginine-specific proteolytic activity predicts graft survival. Transplant Proc 2001, 33(1-2):833-834.
26. Koeppel T.A., Thies J.C., Schemmer P., Trauner M., Gebhard M.M., Otto G., et al. Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow. J Hepatol 1997, 27(1):163-169.
27. Dunne J.B., Piratvisuth T., Williams R., Tredger J.M. Treatment of experimental ischemia/reperfusion injury with S-adenyosylmethionine: evidence that donor pretreatment complements other regimens. Transplantation 1997, 63(4):500-506.
28. Schemmer P., Bradford B.U., Rose M.L., Bunzendahl H., Raleigh J.A., Lemasters J.J., et al. Intravenous glycine improves survival in rat liver transplantation. Am J Phys 1999, 276(4):G924-G932.
29. Schilling M., den Butter G., Saunder A., Lindell S., Belzer F.O., Southard J.H. Membrane stabilizing effects of glycine during kidney cold storage and reperfusion. Transplant Proc 1991, 23(5):2387-2389.
30. Weinberg J.M., Davis J.A., Abarzua M., Rajan T. Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubules. J Clin Invest 1987, 80:1446-1454.
31. Schemmer P., Golling M., Kraus T., Mehrabi A., Mayatepek E., Herfarth C. Extended experience with glycine for prevention of reperfusion injury after human liver transplantation. Transplant Proc 2002, 34:2307-2309.
32. Thurman R.G., Schemmer P., Zhong Z., Bunzendahl H., von Frankenberg M., Lemasters J.J. Kupffer cell dependent reperfusion injury in liver transplantation: new clinically relevant use of glycine. Langenbecks Arch Chir Suppl Kongressbd 1998, 115:185-190.
33. Baros-Schelotto P., Net M., Valero R., Ruiz A., Almenara R., Capdevila L., et al. Reduced reperfusion injury by glycine in a porcine liver transplantation model with non-heartbeating donors. Transplant Proc 2002, 34(4):1114-1117.
34. Zhong Z., Jones S., Thurman R.G. Glycine minimizes reperfusion injury in a low-flow, reflow liver perfusion model in the rat. Am J Phys 1996, 270:G332-G338.
35. Marsh D.C., Vreugdenhil P.K., Mack V.E., Belzer F.O., Southard J.H. Glycine protects hepatocytes from injury caused by anoxia, cold ischemia and mitochondrial inhibitors, but not injury caused by calcium ionophores or oxidative stress. Hepatology 1993, 17:91-98.
36. Ozaki M., Ozasa H., Fuchinoue S., Teraoka S., Ota K. Protective effects of glycine and esterified gamma-glutamylcysteine on ischemia/reoxygenation injury of rat liver. Transplantation 1994, 58:753-755.
37. Schemmer P., Jost J., Conzelmann L.O., Pöschl U., Mehrabi A., Gebhard M.M., et al. Glycine minimizes leukocyte - endothelium interaction after warm ischemia via mechanisms including inactivation of Kupffer cells. Langenbecks Arch Surg Kongressband 2003, 32:455-458.
38. Takei Y., Marzi I., Kauffman F.C., Currin R.T., Lemasters J.J., Thurman R.G. Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker, nisoldipine. Transplantation 1990, 50:14-20.
39. Froh M., Zhong Z., Walbrun P., Lehnert M., Netter S., Wiest R., et al. Dietary glycine blunts liver injury after bile duct ligation in rats. World J Gastroenterol 2008, 14(39):5996-6003.
40. Wheeler M.D., Ikejema K., Enomoto N., Stacklewitz R.F., Seabra V., Zhong Z., et al. Glycine: a new anti-inflammatory immunonutrient. Cell Mol Life Sci 1999, 56(9-10):843-856.
41. Rajendra S., Lynch J.W., Pierce K.D., French C.R., Barry P.H., Schofield P.R. Mutation of an arginine residue in the human glycine receptor transforms beta-alanine and taurine from agonists into competitive antagonists. Neuron 1995, 14(1):169-175.
42. Seabra V., Stachlewitz R.F., Thurman R.G. Taurine blunts LPS induced increases in intracellular calcium and TNF-a production by Kupffer cells. J Leukoc Biol 1998, 64:615-621.
43. Schilling M., den Butter G., Marsh D.C., Belzer F.O., Southard J.H. Glycine inhibits phospholipolysis of hypoxic membranes. Tx Med 1994, 6:140-143.
44. Nichols J.C., Bronk S.F., Mellgren R.L., Gores G.J. Inhibition of nonlysosomal calcium-dependent proteolysis by glycine during anoxic injury of rat hepatocytes. Gastroenterology 1994, 106(1):168-176.
45. D'Souza D.C., Gil R., Cassello K., Morrissey K., Abi-Saab D., White J. IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in humans. Biol Psychiatry 2000, 47:450-462.
46. Arora A.S., Nichols J.C., DeBernardi M., Steers J.L., Krom R.A., Gores G.J. Glycine rinse protects against liver injury during transplantation. Transplant Proc 1999, 31(1-2):505-506.
47. Schemmer P., Golling M., Kraus T., Mayatepek E., Herfarth C., Klar E. Glycine reduces reperfusion injury in human liver transplantation: our first patients. Transplant Proc 2001, 33(7-8):3750-3752.
48. Luntz S.P., Unnebrink K., Seibert-Grafe M., Bunzendahl H., Kraus T., Büchler M.W., et al. HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312]. BMC Surg 2005, 5:18.
49. Azuma J., Sawamura A., Awata N., Ohta H., Hamaguchi T., Harada H., et al. Therapeutic effect of taurine in congestive heart failure: a double blind crossover trial. Clin Cardiol 1985, 8(5):276-282.
50. Matsuyama Y., Morita T., Higuchi M., Tsujii T. The effect of taurine administration on patients with acute hepatitis. Prog Clin Biol Res 1983, 125:461-468.
51. Guan X., Dei-Anane G., Liang R., Gross M.L., Nickkolgh A., Kern M., et al. Donor preconditioning with taurine protects kidney grafts from injury after experimental transplantation. J Surg Res 2008, 146(1):127-134.
52. Foley D.P., Ricciardi T., Traylor A.N. Effect of hepatic artery flow on bile secretory function after cold ischemia. Am J Transplant 2003, 3:148.
53. Wettstein M., Haussinger D. Taurine attenuates cold ischemia reoxygenation injury in rat liver. Transplantation 2000, 69:2290.
54. Wettstein M., Haussinger D. Cytoprotection by the osmolytes betaine and taurine in ischemia-reoxygenation injury in the perfused rat liver. Hepatology 1997, 26:1050.
55. Waterfield C.J., Turton J.A., Scles D.C. Reduction of liver taurine by beta-alanine treatment increases carbon tetrachloride toxicity. Toxicology 1993, 77:7.
56. Kincius M., Liang R., Nickkholgh A., Hoffmann K., Flechtenmacher C., Ryschich E., et al. Taurine protects from liver injury after warm ischemia in rats: the role of Kupffer cells. Eur Surg Res 2007, 39(5):275-283.
57. Hu Y.H., Lin C.L., Huang Y.W., Liu P.E., Hwang D.F. Dietary amino acid taurine ameliorates liver injury in chronic hepatitis patients. Amino Acids 2008, 35(2):469-473.
58. Koeppel T.A., Lehmann T.G., Thies J.C., Gehrcke R., Gebhard M.M., Herfarth C., et al. Impact of N-acetylcysteine on the hepatic microcirculation after orthotopic liver transplantation. Transplantation 1996, 61(9):1397-1402.
59. Braughler J.M. Sulfhydryl group involvement in the modulation of guanosine 3', 5'-monophosphate metabolism by nitric oxide norepinephrine, pyruvate and t-butyl hydroperoxide in minced rat lung. Biochem Pharmacol 1982, 31:3847.
60. Stamler J., Mendelsohn M.E., Amarante P. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 1989, 65:789.
61. Khan A.W., Fuller B.J., Shah S.R., Davidson B.R., Rolles K. A prospective randomized trial of N-acetyl cysteine administration during cold preservation of the donor liver for transplantation. Ann Hepatol 2005, 4(2):121-126.
62. Thies J.C., Teklote J., Clauer U., Tox U., Klar E., Hofmann W.J., et al. The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation. Transpl Int 1998, 11(Suppl. 1):S390-S392.
63. Steib A., Freys G., Collin F., Launoy A., Mark G., Boudjema K. Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation?. Liver Transpl Surg 1998, 4(2):152-157.
64. Jones S.M., Thurman R.G. L-arginine minimizes reperfusion injury in a low-flow, reflow model of liver perfusion. Hepatology 1996, 24(1):163-168.
65. Uhlmann D., Scommotau S., Witzigmann H., Spiegel H.U. Exogenous L-arginine protects liver microcirculation from ischemia reperfusion injury. Eur Surg Res 1998, 30(3):175-184.
66. Schindler G., Kincius M., Liang R., Backhaus J., Zorn M., Flechtenmacher C., et al. Fundamental efforts toward the development of a therapeutic cocktail with a manifold ameliorative effect on hepatic ischemia/reperfusion injury. Microcirculation 2009, 1-10.
67. Nickkholgh A., Schneider H., Encke J., Buchler M.W., Schmidt J., Schemmer P. PROUD: effects of preoperative long-term immunonutrition in patients listed for liver transplantation. Trial 2007, 8:20.
68. Nickkholgh A., Li Z., Yi X., Mohr E., Liang R., Mikalauskas S., et al. Effects of a preconditioning oral nutritional supplement (PONS) on pig livers after warm ischemia. Clin Nutr 2009, 4(Suppl. 2):17.
69. Weigand M.A., Plachky J., Thies J.C., Spies-Martin D., Otto G., Martin E., et al. N-acetylcysteine attenuates the increase in alpha-glutathione S-transferase and circulating ICAM-1 and VCAM-1 after reperfusion in humans undergoing liver transplantation. Transplantation 2001, 72(4):694-698.
70. Taut F.J., Breitkreutz R., Zapletal C.M., Thies J.C., Babylon A., Martin E., et al. Influence of N-acetylcysteine on hepatic amino acid metabolism in patients undergoing orthotopic liver transplantation. Transpl Int 2001, 14(5):329-333.
71. Santiago F.M., Bueno P., Olmedo C., Muffak-Granero K., Comino A., Serradilla M., et al. Effect of N-acetylcysteine administration on intraoperative plasma levels of interleukin-4 and interleukin-10 in liver transplant recipients. Transplant Proc 2008, 40(9):2978-2980.